Top

Cancer Immunology, Immunotherapy

Published in:

01-12-2002 | Symposium Series

Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002

Authors: Malcolm S. Mitchell, Martin W. Kast

Published in: Cancer Immunology, Immunotherapy | Issue 11-12/2002

Title: Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002
Authors: Malcolm S. Mitchell
Martin W. Kast
Publication date: 01-12-2002
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 11-12/2002
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-002-0341-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 11-12/2002

Linomide administration following bone marrow transplantation in mice

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

Analysis of the antibody repertoire of lymphoma patients

Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination

Keynote webinar | Spotlight on antibody–drug conjugates in cancer